HODPRO 50mg capsules medication leaflet

L01XB01 procarbazine • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Methylhydrazines

Procarbazine is an antineoplastic agent used in the treatment of certain types of cancer, such as Hodgkin's lymphoma and other malignant neoplasms. It works by interfering with DNA and RNA synthesis, thereby inhibiting tumor cell growth.

The medication is taken orally, as directed by a doctor, usually as part of a combination chemotherapy regimen. It is important for patients to follow the treatment plan and undergo regular tests to monitor the therapy's effects.

Patients should be aware of potential side effects, such as nausea, vomiting, bone marrow suppression, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and bone marrow suppression. In rare cases, severe reactions such as secondary leukemia or allergic reactions may occur. Patients should be informed of these risks before use.

General data about HODPRO 50mg

Substance: procarbazine

Date of last drug list: 01-06-2025

Commercial code: W71076001

Concentration: 50mg

Pharmaceutical form: capsules

Quantity: 50

Product type: generic

Price: 1378.85 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: NEON LABORATORIES LIMITED - INDIA

Holder: PHARMA S.A. - ROMANIA

Number: 1053/2025/01

Compensation lists for HODPRO 50mg PHARMA

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

1378.85 RON

1378.85 RON

0.00 RON